Isaacs Kim L, Sartor R Balfour
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, 27599-7080, USA.
Gastroenterol Clin North Am. 2004 Jun;33(2):335-45, x. doi: 10.1016/j.gtc.2004.02.006.
Although antibiotics are clearly recognized as having a role in treating the infectious complications of inflammatory bowel diseases (IBD), their impact in the primary treatment of IBD has long been an area of speculation. Over the past decade there is increasing evidence that luminal gut bacteria play a role in the pathogenesis of IBD, particularly Crohn's disease. Compelling evidence that normal commensal bacteria induce chronic intestinal inflammation in susceptible rodents provides an excellent rationale for treatment of human IBD with antibiotics. This article summarizes published studies of antibiotics in IBD patients and reviews available data for the use of antibiotic therapy in Crohn's disease and ulcerative colitis.
尽管抗生素在治疗炎症性肠病(IBD)的感染性并发症方面的作用已得到明确认可,但其在IBD初始治疗中的影响长期以来一直是一个备受猜测的领域。在过去十年中,越来越多的证据表明肠道内细菌在IBD,尤其是克罗恩病的发病机制中发挥作用。正常共生细菌在易感啮齿动物中引发慢性肠道炎症的有力证据为使用抗生素治疗人类IBD提供了很好的理论依据。本文总结了已发表的关于IBD患者使用抗生素的研究,并综述了在克罗恩病和溃疡性结肠炎中使用抗生素治疗的现有数据。